141925-59-9 Usage
Check Digit Verification of cas no
The CAS Registry Mumber 141925-59-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,1,9,2 and 5 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 141925-59:
(8*1)+(7*4)+(6*1)+(5*9)+(4*2)+(3*5)+(2*5)+(1*9)=129
129 % 10 = 9
So 141925-59-9 is a valid CAS Registry Number.
InChI:InChI=1/C51H62N12O7/c1-30(53)45(64)60-44(26-37-28-55-29-57-37)51(70)63-48(67)41(18-10-11-21-52)59-49(68)42(24-32-12-4-3-5-13-32)62-50(69)43(25-36-27-56-40-17-9-8-16-38(36)40)61-46(65)31(2)58-47(66)39(54)23-33-19-20-34-14-6-7-15-35(34)22-33/h3-9,12-17,19-20,22,27-31,37,39,41-44,56H,10-11,18,21,23-26,52-54H2,1-2H3,(H,58,66)(H,59,68)(H,60,64)(H,61,65)(H,62,69)(H,63,67,70)/t30-,31-,37?,39+,41-,42+,43-,44-/m0/s1
141925-59-9Relevant articles and documents
PEPTIDOMIMETICS FOR IMAGING THE GHRELIN RECEPTOR
-
Page/Page column 21; 22; 26, (2016/12/22)
ABSTRACT The present invention concerns compositions comprising and methods of identification and use of imaging agents. The imaging agents comprise a growth hormone secretagogues having a conjugated fluoride. The imaging agents of the present invention may be used for detection, diagnosis and/or staging of prostate or other forms of cancer, and may also be used for cardiac disease.
